CAD Staging Guide
The first clinical staging system for disease burden of atherosclerotic plaque, which is the direct cause of coronary artery disease (CAD).
Access Our CAD Staging Guide
The goal of the staging system is to be able to standardize disease severity based on the primary cause of CAD—atherosclerotic plaque—and not secondary surrogates, which has represented a historical standard of care for nearly 7 decades.
– Andrew Freeman, MD
Director of Cardiovascular Prevention and Wellness at National Jewish Health
Impact on Cardiovascular Care
Being able to measure plaque using CCTA technology is an important step in addressing CAD, but it’s just the beginning. The next step is developing a personalized and optimal treatment plan based on the disease burden. As with cancer and common chronic conditions, this plan varies based on the stage of disease progression – further emphasizing the importance of a staging system for CAD.
Ready to Learn More?
Schedule a demo with us to explore Cleerly and how you can leverage our technology to improve patient care.